Emad Eldin Hassan

949 total citations
21 papers, 788 citations indexed

About

Emad Eldin Hassan is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Emad Eldin Hassan has authored 21 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmaceutical Science and 3 papers in Biomaterials. Recurrent topics in Emad Eldin Hassan's work include Drug Solubulity and Delivery Systems (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Emad Eldin Hassan is often cited by papers focused on Drug Solubulity and Delivery Systems (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Emad Eldin Hassan collaborates with scholars based in Egypt and United States. Emad Eldin Hassan's co-authors include James M. Gallo, Roy C. Parish, Labiba K. El‐Khordagui, Magda A. El-Massik, Ibrahim A. Darwısh, Azza Elkady, ‏Helal F. Hetta, Asmaa M. Zahran, Aly Nada and Mona A. Mohammed and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Emad Eldin Hassan

18 papers receiving 757 citations

Peers

Emad Eldin Hassan

BIOMA

PHEOH

Mohamed M. Badran Saudi Arabia

Angela Fabiano Italy

Ni Zeng China

Rania A.H. Ishak Egypt

Sarita Kumari Yadav India

Abdullah H. Alomrani Saudi Arabia

Vivek Ghate India

Rasha A. Khallaf Egypt

Somnath Singh United States

Meenakshi Kanwar Chauhan India

Mohamed M. Badran Saudi Arabia

Emad Eldin Hassan

366 ×0.9

171 ×1.1

BIOMA

189 ×1.2

78 ×0.9

41 ×0.5

PHEOH

Citations per year, relative to Emad Eldin Hassan Emad Eldin Hassan (= 1×) peers Mohamed M. Badran

Countries citing papers authored by Emad Eldin Hassan

Since Specialization

Citations

This map shows the geographic impact of Emad Eldin Hassan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emad Eldin Hassan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emad Eldin Hassan more than expected).

Fields of papers citing papers by Emad Eldin Hassan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emad Eldin Hassan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emad Eldin Hassan. The network helps show where Emad Eldin Hassan may publish in the future.

Co-authorship network of co-authors of Emad Eldin Hassan

This figure shows the co-authorship network connecting the top 25 collaborators of Emad Eldin Hassan. A scholar is included among the top collaborators of Emad Eldin Hassan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emad Eldin Hassan. Emad Eldin Hassan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hassan, Emad Eldin, et al.. (2025). Added value of delayed imaging after diuretic injection in evaluation of cases of bladder cancer with PET. Nuclear Medicine Communications. 46(12). 1249–1255.

Hassan, Emad Eldin, et al.. (2024). CASE-CONTROL STUDY OF INTESTINAL PARASITES IN PATIENTS WITH INTESTINAL CANCER IN SOHAG, EGYPT. Journal of the Egyptian Society of Parasitology. 54(2). 319–324. 2 indexed citations

Hassan, Emad Eldin, et al.. (2023). CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia. Annals of Hematology. 103(3). 781–792. 4 indexed citations

Hassan, Emad Eldin, et al.. (2020). Does extent of resection of glioblastoma multiforme affect survival?. Journal of Clinical Oncology. 38(15_suppl). e14514–e14514.

Sedky, A., et al.. (2020). Predictors of Recurrence of Hepatocellular Carcinoma after Transarterial Chemoembolization: Role of Hepatocyte Growth Factor. Open Journal of Gastroenterology. 10(6). 151–165. 1 indexed citations

Hetta, ‏Helal F., et al.. (2019). Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention. 20(6). 1927–1933. 27 indexed citations

Hetta, ‏Helal F., Asmaa M. Zahran, Nahed Mohamed, et al.. (2019). Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer. MicroRNA. 8(3). 206–215. 37 indexed citations

Hassan, Emad Eldin, et al.. (2018). Effect of Cranberry on biofilm formation by P. mirabilis isolated from Patients Suffering from Urinary tract Infections. Research Journal of Pharmacy and Technology. 11(3). 1097–1097.

El–Gengaihi, S., et al.. (2013). Chemical Composition and Biological Evaluation ofPhysalis peruvianaRoot as Hepato-renal Protective Agent. Journal of Dietary Supplements. 10(1). 39–53. 23 indexed citations

10.

El–Gengaihi, S., et al.. (2012). Chemical composition and nutritional effect of Physalis peruviana husk as hepato-renal protective agent. International Journal of Phytomedicine. 4(2). 229–236. 1 indexed citations

11.

Hassan, Emad Eldin, et al.. (1998). Effects of some beta-adrenergic blockers on male fertility parameters in rats.. PubMed. 105(1). 10–2. 14 indexed citations

12.

Darwısh, Ibrahim A., Magda A. El-Massik, Emad Eldin Hassan, & Labiba K. El‐Khordagui. (1996). Assessment of a hydroalcoholic surfactant solution as a medium for the dissolution testing of phenytoin. International Journal of Pharmaceutics. 140(1). 25–32. 4 indexed citations

13.

El-Massik, Magda A., Ibrahim A. Darwısh, Emad Eldin Hassan, & Labiba K. El‐Khordagui. (1996). Development of a dissolution medium for glibenclamide. International Journal of Pharmaceutics. 140(1). 69–76. 32 indexed citations

14.

Hassan, Emad Eldin, et al.. (1995). Formulation of prolonged release lipid micropellets by emulsion congealing: Optimization of ketoprofen entrapment and release. International Journal of Pharmaceutics. 121(2). 149–155. 17 indexed citations

15.

Gallo, James M., et al.. (1993). Targeting anticancer drugs to the brain: II. Physiological pharmacokinetic model of oxantrazole following intraarterial administration to rat glioma-2 (RG-2) bearing rats. Journal of Pharmacokinetics and Biopharmaceutics. 21(5). 575–592. 21 indexed citations

16.

Hassan, Emad Eldin & James M. Gallo. (1993). Targeting Anticancer Drugs to the Brain. I: Enhanced Brain Delivery of Oxantrazole following Administration in Magnetic Cationic Microspheres. Journal of drug targeting. 1(1). 7–14. 51 indexed citations

17.

Hassan, Emad Eldin & James M. Gallo. (1992). High-performance liquid chromatographic analysis of the anticancer drug oxantrazole in rat whole blood and tissues. Journal of Chromatography B Biomedical Sciences and Applications. 582(1-2). 225–231. 4 indexed citations

18.

Hassan, Emad Eldin, Roy C. Parish, & James M. Gallo. (1992). Optimized Formulation of Magnetic Chitosan Microspheres Containing the Anticancer Agent, Oxantrazole. Pharmaceutical Research. 9(3). 390–397. 122 indexed citations

19.

Hassan, Emad Eldin & James M. Gallo. (1990). A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength. Pharmaceutical Research. 7(5). 491–495. 376 indexed citations

20.

Gallo, James M. & Emad Eldin Hassan. (1988). Receptor-Mediated Magnetic Carriers: Basis for Targeting. Pharmaceutical Research. 5(5). 300–304. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact